MTLC — MTL Cannabis Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual income statement for MTL Cannabis, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2020 April 30th	2021 April 30th	2022 July 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	15 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5.31	10.6	26.7	65.3	84.1
Cost of Revenue
Gross Profit	4.17	4.49	13.1	29.8	46.4
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	15.1	19.1	33.3	60.7	68
Operating Profit	-9.79	-8.55	-6.68	4.61	16.1
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-9.71	-11.3	-11.1	1.79	8.65
Provision for Income Taxes
Net Income After Taxes	-9.52	-11.4	-11.1	2.45	6.83
Net Income Before Extraordinary Items
Net Income	-9.52	-11.4	-11.1	2.45	6.83
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-9.52	-11.4	-11.1	2.45	6.83
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.822	-0.45	-0.34	0.049	0.045
Dividends per Share